Targeting a specific enzyme in the muscle could help cancer patients preserve muscle mass and potentially prolong their survival, according to research from UTHealth Houston.
A study led by Yi-Ping Li, PhD, professor in the Department of Integrative Biology and Pharmacology, found that an enzyme known as UBR2 plays a critical role in cancer-induced muscle wasting, also called cancer cachexia.
The results are published in the scientific journal PNAS.
To read the entire article, click here.